Abstract:Background: Total hip arthroplasty (THA) is a well-established and effective treatment for advanced osteoarthritis (OA) of the hip joint. While commonly performed in older patients, THA is increasingly used in younger individuals, especially in cases of secondary coxarthrosis. Technological advances have led to the development of specialized implants, which allow surgeons to address severe post-inflammatory or dysplastic deformities. Younger patients undergoing THA, often in their 20s or 30s, present higher functional expectations. Despite limited long-term studies, research indicates a higher rate of revision surgeries in this age group compared to older populations, making these procedures a unique challenge. Methods: This retrospective study analyzed 5263 primary total hip arthroplasties (THAs) performed at our center between May 1985 and December 2016. After excluding cemented and hybrid implants, as well as patients lost to follow-up or with other etiologies, 101 uncemented THA procedures in 92 patients aged 30 years or younger were included. The majority (64.4%) were due to dysplastic coxarthrosis (DDH), while avascular necrosis (26.7%) and juvenile rheumatoid arthritis (8.9%) accounted for the rest. The average patient age was 25.6 years, with a mean follow-up period of over 24 years. Surgical technique involved the anterolateral approach, with implants placed in the true acetabular region. Implants included Munich/Plasmacup, Mittelmeier, and P-M designs. Implant survival was estimated using the Kaplan–Meier estimator to determine the probability of implant longevity over the follow-up period. Outcomes were assessed using Merle d'Aubigné and Postel scores, modified by Charnley, alongside radiographic evaluations based on the Crowe, De Lee, and Gruen classifications. Results: Preoperatively radiological assessment of all hips was classified as grade IV according to the Kellgren–Lawrence scale. Over an average follow-up of 24 years, final outcomes using the modified Merle d'Aubigné and Postel (MAP) classification were excellent in 24%, good in 37%, satisfactory in 8%, and poor in 32% of cases. Results compared between DDH group and control group indicate significantly more poor results for the DDH group compared to the control group (p-value < 0.05). All poor outcomes were associated with prosthesis loosening, primarily involving P-M and Mittelmeier acetabular components. Complications included intraoperative fractures in five cases, peripheral nerve dysfunction in six cases, and heterotopic ossification in eight cases. Postoperative pain scores on the VAS scale improved from 6.8 to 1.7. The Kaplan–Meier estimator indicated 10-year survival rates of 85.2% for the entire prosthesis, with 69.8% survival at 15 years and 54.5% at 20 years. For each period the bio-functionality according to Kaplan–Meier estimator was in favor of the control group. Conclusions: Cementless THA in patients aged 30 or younger has demonstrated itself to be an efficacious treatment for hip osteoarthritis, yielding favorable bio-functional outcomes in both short- and long-term follow-up. Nevertheless, THA performed in the context of developmental dysplasia of the hip (DDH) carries a significantly elevated risk of postoperative complications, most notably aseptic loosening, which critically undermines implant survival rates. Given the young demographic and the anticipated prolonged functional lifespan of the prosthesis, there is an increased propensity for loosening over time, necessitating vigilant and sustained postoperative surveillance.

Clinical analysis of the treatment of developmental dysplasia of the hip in adults with the total hip replacement

[Total Hip Arthroplasty for Crowe Type IV Developmental Dysplasia of the Hip with S-ROM Prosthesis].

Total hip arthroplasty for the treatment of severe developmental dysplasia of the hip in adults

Total Hip Arthroplasty with Cementless Cups and Femoral Head Autografts for Patients with Hip Dysplasia and Osteoarthritis

Clinical Application of Total Hip Arthroplasty with a Short-Neck and Straight Stem for Treatment of Developmental Dysplastic Hip with High Dislocation

Surgical treatment for developmental dysplasia of hip in older children

[Total Hip Arthroplasty with Uncemented Cup and Femoral Head Autografts for Coxarthrosis Due to Dysplasia].

[Total Hip Arthroplasty Combined with Femoral Head Autograft for Crowe Type II and Type III Developmental Dysplasia of Hip].

Total Hip Replacement for Dysplasia of the Acetabulum in Adults

Total Hip Arthroplasty in Patients Who Have Crowe Type IV Developmental Dysplasia of the Hip: A Systematic Review

Outcome analysis of different surgical methods for the treatment of hip dysplasia

Total hip arthroplasty in developmental dysplasia of the hip patients: Mid-term results

A 24-Year Follow-Up Study with a Minimum 8-Year Follow-Up, Focused on Developmental Dysplasia of the Hip

Medium- to long-term clinical efficacy of total hip arthroplasty with structural bone grafting for dysplasia of the hip

Clinical evaluation of direct anterior approach total hip arthroplasty for severe developmental dysplasia of the hip

Robotic-assisted total hip arthroplasty in patients with developmental dysplasia of the hip

[Artificial Intelligence Assisted Total Hip Arthroplasty for Patients with Crowe Type Ⅳ Developmental Dysplasia of the Hip].

Total hip replacement in patients with congenrital acetabular dysplasia

[Application of high hip center technique in total hip arthroplasty in patients with Crowe typeⅡand Ⅲ developmental dysplasia of hip and severe hip osteoarthritis]

A clinical study on total hip arthroplasty caused by progressive pseudorheumatoid dysplasia

Mid-term to Long-term Outcomes and Complications of Total Hip Arthroplasty in Patients Who Have Crowe IV Developmental Dysplasia of the Hip: A Systematic Review and Meta-Analysis